Serum institute of India aims to launch COVID-19 vaccine every quarter, CEO Adar Poonawalla said on Thursday, as reported by Reuters.
The central government ordered 1.1 crore doses of the oxford-AstraZeneca vaccine which costs Rs 200 per dose for first 10 crore doses.
Poonawalla also revealed that the pharma is increasing its production capacity by the end of 2021 to over 250 crore doses.
Serum institute which is a pune based pharma partnered with UD based Codagenix to manufacture and supply its COVID-19 vaccine. As India is a largest pharma producing country which also entered in to partnership with international vaccine alliance GAVI and the Bill and Melinda Gates which will deliver up to 20 crore doses of novel Coronavirus vaccine, Livemint Reported.
India the largest producer of pharma sector will increase the export growth sector for the economy and generates revenue to the country.